STATUS: ONGOING

In 2022, AIC OJSC, in partnership with Diamed Development Group LLC, jointly invested in the "Intravenous Infusion Solutions Production Plant" project. Infusion solutions are essential for maintaining the body's water-electrolyte balance and supporting optimal metabolic function. The project primarily focuses on the production of Sodium Chloride (0.9%), Glucose (5%), Ringer and Ringer Lactate.

This initiative represents a significant step toward enhancing the effectiveness of infusion therapies in the medical field and improving patient health outcomes. The project aims to supply high-quality, reliable infusion solutions through the use of modern production technologies.

Total cost of the project: AZN 15.6 million

Number of workplaces: 51

Investment year: 2022